openPR Logo
Press release

Understanding COVID-19’s impact on the Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market

08-10-2020 09:01 AM CET | Health & Medicine

Press release from: Allied Market Research

Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market

Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market

Global CRPC therapeutics market would generate a revenue of $9.5 billion by 2020, registering a CAGR of 9.1% from 2015 to 2020. Hormonal therapy segment spearheads among all the therapy types, governing around 4/5th of the global market value in 2014 and would sustain its market position throughout 2020.

Download free sample Report @ alliedmarketresearch.com/request-sample/694

The global CPRC therapeutics market has witnessed high growth in the past few years and would continue to grow at a consistent pace due to the high unmet clinical need associated with the disease. Large amount of drugs in pipeline, augmented patient awareness and untapped nmCRPC space would largely drive the market growth during the forecast period. On the other hand, introduction of novel treatments would be difficult as long as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) require an improvement in overall survival period. Moreover, lack of differentiation in mechanism of action among the approved and novel agents along with factors such as premium pricing and uncertain reimbursement policies would hinder the market growth during the analysis period.

The market would gain traction in the emerging countries of Asia-Pacific and third-world countries such as Africa and Latin America. Asia Pacific and LAMEA region would collectively constitute around 1/3rd of the overall market by 2020. The large undiagnosed patient population, rapid urbanization, rising disposable income, improved government funding towards healthcare and growing awareness about prostate cancer would be the prime reasons responsible for the impressive market growth in these regions. The market growth would mainly rely on the novel breakthrough treatments with improved overall survival benefits. The survival benefit would be instrumental in governing the peak sales and market penetration of novel approved drugs.

Key findings of the study:

North America CRPC market spearheads the regional CRPC markets and would continue to lead throughout the forecast period
Radiotherapy segment is projected to grow at a CAGR of 24.5% throughout the forecast period, fastest among all CRPC therapy segments
Immunotherapy segment is expected to grow more than threefold over the forecast period
Asia Pacific CRPC market is expected to garner 1/5th of the overall market revenue by 2020
European market is expected to expand more than two-fold as compared to North American market (within hormonal therapy segment) over the forecast period
Countries like India and China holds immense future market potential as there is a higher count of undiagnosed CRPC patients.

Discount on Purchase @ https://www.alliedmarketresearch.com/purchase-enquiry/694

The principal and key strategy adopted by the leading players in the market is product launch. In order to implement the strategy, acquisitions and partnerships/collaborations have been the key strategies adopted by the leading industry players. The key companies profiled in the report are Astellas Inc., Johnson & Johnson, Sanofi S.A, Dendreon Corporation, Bayer AG, and others.

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Life Science Market: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Understanding COVID-19’s impact on the Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market here

News-ID: 2107932 • Views: 304

More Releases from Allied Market Research

Aircraft Hose Fittings Market 2027 Top Players, Key Statistics and Business Deve …
The global aircraft hose fittings market is segmented based on the material, application, part, flexibility, aircraft type, and region. Based on material, the segmentation is done into rubber, PTFE, metals, and others. The applications covered in the study include lubrication, air, hydraulic, fuel, and others. By part, the market is segregated into swivel fittings, couplings, clamps & straps, and flexible joints & ducts. As per flexibility, it is fragmented into
Advanced Gear Shifter System Market 2027 Growth, Analysis: Tips From The Great D …
The advanced gear shifter system is an electronically controlled system, which is responsible for engagement and disengagement of gear. It uses a lever and an electronic system to engage /disengage or change gears according to the requirement of the driver. In a manual transmission system, gear shifting can be a tiring task, this is eliminated by the advanced gear shifter system. This system identifies when the driver is changing the
Automotive Slipper Clutch Market in-Depth Analysis, Key Players, Challenges, Seg …
Automotive Slipper Clutch Market by Product Type (Carbon Steel, Diamond Edged, Multi Hole Saws, Specialty Hole Saws, and Others), by End-user Industry (Commercial and Domestic), and by Application (Wet Drilling and Dry Drilling) – Global Opportunity Analysis and Industry Forecast, 2019-2026.” The report has offered an all-inclusive analysis of the global automotive slipper clutch Market taking into consideration all the crucial aspects like growth factors, constraints, market developments, top investment
North American Drivetrain Market Outlook On The Basis Of Product, Application, P …
The drivetrain system constitutes of various components that are used to deliver power for driving wheels of a vehicle. It excludes engine or motor that generates power. The main function of drivetrain is to convert power of engine into mechanical energy that drive wheels. The components in drivetrain includes transmission, driveshaft, propeller shaft, clutch/torque converter, transfer case, differential, and others. The components in drivetrain vary according to the type of

All 5 Releases


More Releases for CRPC

Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Booming by …
Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon
Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Siz …
Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after administering androgen deprivation therapy (ADT), is gaining prominence in the prostate cancer market. The global CRPC market is poised to expand at a significant pace, owing to high unmet clinical need, limited survival benefits, growing prevalence rates and fast emerging treatment modifications. The market growth would pivot around the novel breakthrough
Castration-Resistant Prostate Cancer (CRPC) Treatment Market- Evolving Manufactu …
HTF MI published a new industry research that focuses on Castration-Resistant Prostate Cancer (CRPC) Treatment market and delivers in-depth market analysis and future prospects of Global Castration-Resistant Prostate Cancer (CRPC) Treatment market. The study covers significant data which makes the research document a handy resource for managers, analysts, industry experts and other key people get ready-to-access and self-analyzed study along with graphs and tables to help understand market trends, drivers
Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Research Rep …
The report entitled Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market : Size, Trends & Forecasts (2017-2021), provides analysis of the Global Castration-Resistant Prostate Cancer (CRPC) Treatment, with detailed analysis of market size and growth, and segmentation of the industry. The analysis includes the market by value, by segments, by application and by region. The report also provides the analysis of the Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market of
Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Res …
This report studies Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Astellas Johnson & Johnson Sanofi Dendreon Bayer To Get Sample Copy of Report visit @ http://www.qyresearchreports.com/sample/sample.php?rep_id=905816&type=E Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth
Castration-Resistant Prostate Cancer (CRPC) Therapeutics Market to Reach $9.5 Bi …
The principal and key strategy adopted by the leading players in the market is product launch. In order to implement the strategy, acquisitions and partnerships/collaborations have been the key strategies adopted by the leading industry players. The key companies profiled in the report are Astellas Inc., Johnson & Johnson, Sanofi S.A, Dendreon Corporation, Bayer AG, and others. CRPC Therapeutics Market Report, published by Allied Market Research, forecasts that the global market